Sage Journals: Discover world-class research

Free access

Research article

First published 2018-5

ESR1 and PIK3CA mutational status in serum and plasma from metastatic breast cancer patients: A comparative study

Takashi Takeshita, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki [...]

Cancer Biomarkers

Open access

Case report

First published 2024

Elacestrant plus alpelisib in an ESR1 and PIK3CA co-mutated and heavily pretreated metastatic breast cancer: the first case report for combination efficacy and safety

Ünal Metin Tokat, Şevval Nur Bilgiç, Esranur Aydın [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2021

Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer

Ming Li, Mengdie Shi, Ying Xu [...]

Cell Transplantation

Open access

Review article

First published 2022

Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer

Song Xia, Qiong Lin

Technology in Cancer Research & Treatment

Open access

Review article

First published 2022

Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role

Maxwell R. Lloyd, Seth A. Wander, Erika Hamilton [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Options after progression on first-line CDK4/6 inhibitors in advanced breast cancer patients

Xiaomeng Jia, Kainan Wang, Xueqing Wang [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

AMEERA-5: a randomized,double-blind phase 3 study of amcenestrant plus palbociclib versus letrozole plus palbociclib for previously untreated ER+/HER2– advanced breast cancer

Aditya Bardia, Javier Cortes, Sara A. Hurvitz [...]

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2024-8

Elacestrant for ER-Positive HER2-Negative Advanced Breast Cancer

Elizabeth Hageman, Mia E. Lussier

Annals of Pharmacotherapy

Retricted access

Research article

First published 2023-9

Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments,evidence,and recommendations

Clement Chung, Vanessa T.Y. Yeung, Kenneth C.W. Wong

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2024-6

Bioinformatics Analyzes the Mechanisms of Codonopsis Radix in Treating Ovarian Cancer

Zhenhui Chen, Yan Zhou, Yun Shen [...]

Pharmacognosy Magazine

Search results